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ABSTRACT
Objective: To analyze the results and determine the con-
tribution of laparoscopic pelvic lymphadenectomy in the
surgical treatment of women with endometrial cancer
and compare with the open technique. 
Methods: A prospective multicenter study was carried
out on 120 women who underwent laparoscopic surgery
(96 women) and open procedures (24 women) for
endometrial cancer between April 1996 and March 2000. 
Results: Four patients whose laparoscopic surgery was
completed by laparotomy were excluded from the study.
The other 92 laparoscopic procedures were successfully
completed. Laparoscopically assisted surgical staging
(LASS) was performed based on the grade of the tumor
and the depth of myometrial invasion. Sixty-seven of the
patients underwent hysterectomy, bilateral salpingo-
oophorectomy (BSO), and pelvic lymphadenectomy, and
25 women also had para-aortic lymph node sampling
dissection. Eleven of these patients had positive pelvic or
para-aortic nodes. The mean operating time for the
laparoscopic procedure was significantly longer (173.8
min, P < 0.0001) than the time for the open procedure
(135.0 min). The rate of complications was similar in
both groups. The recovery time was significantly reduced
(P < 0.0001). 
Conclusion: The laparoscopic approach to hysterecto-
my and lymphadenectomy for early stage endometrial
carcinoma is an attractive alternative to the abdominal
surgical approach. The advantages of laparoscopically
INTRODUCTION
Endometrial cancer is the most common gynecological
cancer, with an incidence in the Czech Republic of about
30 cases per 100,000 women per year. Surgical treatment
was traditionally performed by laparotomy; the laparo-
scopic approach, however, has gained wider acceptance
by gynecologic oncologists. Several reports of laparo-
scopic staging of pelvic malignancy have been report-
ed.1-4 
The Gynaecologic Oncology Group (GOG) initiated 2
prospective feasibility trials at 6 institutions with a spe-
cific interest in laparoscopic surgery.5 The Gynaecologic
Oncology Group studies laparoscopic retroperitoneal
lymph node sampling followed by laparoscopically
assisted vaginal hysterectomy (LAVH) and bilateral salp-
ingo-oophorectomy (BSO) in women with early stage
endometrial cancer. Operating time, blood loss, duration
of hospital stay, return to normal activity, and complica-
tions are evaluated. Node count, video recordings, and
pathology review evaluate the adequacy of the proce-
dure. 
Based on the above criteria, the Czech multicenter
prospective trial (CZEMPT) began in 1996, and the pre-
liminary results of our study have been reported.6 The
primary aim of the study is to report the perioperative
and postoperative outcomes of laparoscopic transperi-
toneal lymphadenectomy in a major group of patients
with endometrial cancer. The second aim is to assess the
contribution of pelvic lymphadenectomy to laparoscopi-
cally assisted surgical staging (LASS). 
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assisted surgical staging are patient related. Because the
abdominal incision is avoided, the recovery time is
reduced. Laparoscopic pelvic lymph node dissection is a
procedure that is appropriate, when applicable. 
Key Words: Laparoscopic lymphadenectomy, Endo-
metrial cancer.
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MATERIALS AND METHODS
This study was conducted at 3 oncolaparoscopic centers
in the Czech Republic. We identified 192 patients who
underwent surgery for early-stage endometrial cancer
between April 1996 and March 2000. Only 120 women
who had undergone laparoscopic (96 women) or abdom-
inal (24 women) lymphadenectomy and hysterectomy
with bilateral salpingo-oophorectomy (BSO) were includ-
ed in the study. Seventy-two patients who underwent
only laparoscopic, vaginal, or abdominal hysterectomy
with BSO were excluded. A group of 24 patients, who
underwent abdominal hysterectomy, salpingo-oophorec-
tomy, and retroperitoneal lymph node dissection, was
used as a control (open) group. 
Selection criteria for the laparoscopic approach included
clinician suspicion of early stage endometrial cancer,
regardless of grade or histo-pathology and myoinvasion,
as well a mobile uterus amenable to a laparovaginal
approach for hysterectomy. The decision concerning the
extent of laparoscopic surgery was based on the guide-
lines suggested by Childers et al1 and included in the
CZEMPT protocol.6 The study protocol was approved by
the Regional Committee on Human Research at the
Hospital Kladno, and the participants gave informed con-
sent at enrollment. The study was supported by the Grant
Fund of the Health Ministry. 
The patients who underwent abdominally assisted surgi-
cal staging (ASSS) had a standard open procedure with a
vertical midline incision, total hysterectomy, bilateral
salpingo-oophorectomy, peritoneal washing, pelvic
lymph node dissection, and, in the presence of selected
high-risk factors para-aortic sampling as well. For the
open procedure, patients were selected who were not
suitable for laparoscopic surgery because of the following
reasons: concurrent illness that does not allow the use of
the Trendelenburg position, high anesthesiology risk
according to the classification of ASA (American Society
of Anesthesiologists) III, and an enlarged myomatous
uterus, in which the necessity for morcellation can be a
prerequisite, and a history of repeated laparotomies for
peritonitis. 
A complete history was taken preoperatively of all the
patients with clinical stage I carcinoma of the endometri-
um. All the patients underwent endometrial biopsy, ultra-
sound, and computerized tomography (CT) or magnetic
resonance imaging (MRI). 
All the procedures were carried out by 1 of 3 experi-
enced oncogynecological surgeons. A video recording
was taken of each patient. A case record form was com-
pleted that contained patient identification data, preop-
erative staging results (ultrasound, CT, MRI, and biopsy),
surgical/pathological information (grading, myometrial
invasion, typing, and cytology), and the definitive staging
was completed. The types of surgery and characteristics
of the women are shown in Table 1. 
Laparoscopic Operating Technique
Laparoscopy, with the use of video monitoring equip-
ment, was carried out with the patient in the lithotomy
position. The telescope was inserted at the subumbilical
site and one 10-mm port of entry was made suprapubi-
cally and medially. Finally, two or three 5-mm ports were
placed in each of the lower quadrants at the lateral edge
of the rectus muscle. Bipolar and monopolar electro-
cauterers (Karl Storz Endoscope, Tuttlingen, Germany)
were used in most cases, whereas a Harmonic scalpel
and LaparoSonic coagulating shears (LCS-K5),
(UltraCision, Ethicon Endo Surgery, Johnson & Johnson
Ltd, Cincinnati, Ohio, USA) were applied in some cases
at 1 center only (Hospital Kladno). 
Table 1.
Types of Surgery and Patient Characteristics.
Laparoscopy Control Group Totals
Type of Surgery
HYE, BSO, PLN 67 21 88
HYE, BSO, PLN, PALN 25 3 28
Totals 92 24 116
Patient Characteristics P value
BMI 27.1 26. 7 NS
Range 18. 7-43.1 18. 7-32. 9
Age (years) 59. 4 59. 5 NS
Range 42-76 47-79
Values are means and ranges; HYE=hysterectomy; BSO=bilateral
salpingo-oophorectomy; PLN=pelvic lymph node dissection;
PALN=para-aortic lymph node dissection; NS=not significant;
BMI=body mass index.Laparoscopically assisted surgical staging required a
complete inspection of the whole peritoneal cavity.
Intraperitoneal fluid was aspirated in each of 4 quadrants
for cytological investigation. A second look laparoscopy
was then performed to secure or confirm hemostasis,
and an intraperitoneal drain was left in situ until the next
day. All patients received thrombosis prophylaxis in a
form of low molecular heparin and also perioperative
prophylactic antibiotics. 
Transperitoneal Pelvic Lymph Node Dissection
The dissection was begun by opening the broad ligament
and lateral pelvic peritoneum between the round liga-
ment and the infundibulopelvic ligament. The lymph
nodes bearing the adipose tissue were excised from the
obturator fossa after mobilization of the external and
internal iliac vessels and obturator nerve and vessels as
well. We dissected the lymph nodes up to the level of
bifurcation of the iliac vessels superiorly and to the
femoral canal inferiorly. The paravesical and pararectal
spaces were opened with blunt and sharp dissection.
The ureter was visualized along the medial leaf of the
peritoneum at the level of the bifurcation of the common
iliac artery. 
Transperitoneal Para-Aortic Lymph Node
Dissection (PALN) or Sampling (PALS)
The para-aortic lymph node dissection was initiated by
incising the peritoneum, which lies over the right com-
mon iliac artery, extending the incision cranially along
the aorta up to the level of the inferior mesenteric artery.
Only the lymph node sampling was performed from the
para-aortic fields between the level of the inferior mesen-
teric artery and the level of the renal artery. Para-aortic
lymph node dissection was done after the pelvic lymph
node dissection. The nodal package was removed from
the operative field through the upper 10-mm trocar. 
Laparoscopy-Assisted Vaginal Hysterectomy with
Vaginal Colpotomy (LAVH-VC)
The hysterectomy was begun with laparoscopy. The fol-
lowing steps were performed during the laparoscopic
phase: severing of the round ligament, dissection of the
upper portion of the broad ligament, severing of the
infundibulopelvic ligament, preparation of the bladder
flap, and severing of the bladder pillars. These steps
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were finalized vaginally severing the uterine vessels, car-
dinal uterosacral ligament, performance of anterior and
posterior culdotomy, and closure of the vaginal cuff. 
The anterior peritoneum of the broad ligament was dis-
sected towards the bladder. After the dissection of the
bladder from the lower uterine segment, an inspection
was carried out on each side to visualize the ureter and
uterine artery. 
Laparoscopy-Assisted Vaginal Hysterectomy with
Laparoscopic Colpotomy (LAVH-LC)
All steps, including dissection of a uterine artery origin
from the hypogastric artery, were performed laparoscop-
ically, except severing of vaginal branches of the uterine
vessels and closure of the vaginal cuff, which were com-
pleted vaginally. Koh’s cup was placed over the cervix in
LAVH-LC patients only. The cup was used alone with a
uterine manipulator or as part of a new system described
by Koh in 1998.7 Principally, this system consists of lift-
ing the neck and straining the vaginal vault with a plas-
tic vaginal cuff manipulator. Distancing of uterine vessels
from the ureter and safe dissection of uterine vessels and
vaginal vaults were subsequently performed. 
Statistical Analysis 
We evaluated and compared differences in the perioper-
ative and postoperative outcomes of the 2 groups
(laparoscopy and open) of patients with different surgery
techniques of endometrial cancer staging. Data regarding
the duration of the surgery, the number of lymph nodes,
the blood loss, and the length of hospital stay were col-
lected. The differences between the 2 groups were deter-
mined by the unpaired t test by an independent biome-
trician. A P-value of less than 0.05 was considered sig-
nificant. 
RESULTS 
The results are summarized in Tables 2-5. The laparo-
scopic procedure was completed successfully in 92
women (95.8%). The electrosurgery procedure of
laparoscopy was carried out in 77 patients, and ultrason-
ic operative techniques with a Harmonic scalpel and
shears were used in 1 center only (15 women). We were
unable to perform prompt and thorough hemostasis in 1
obese patient due to ineffective post-LaparoSonic coagu-
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was effective in this case, however. Electrosurgery was
effective in all cases. We converted to laparotomy in 4
patients: 1 woman had uncontrolled bleeding from a
branch of the iliac vein, 1 patient had oxygen hypoventi-
lation during anesthesia, and 2 others sustained an injury
to the epigastric artery and had extensive fibrotic adhe-
sions and uncontrolled bleeding. These patients were
removed from data analysis, but they remained in the
laparoscopic group for analysis of complications only. An
overview of pre- and postoperative complications is
shown in Table 5. 
The mean age and range of age distribution were similar
in the 2 groups (Table 1). The mean age in the laparo-
scopic group was 59.4 years, compared with 59.5 years in
the open group. The difference in body mass index (BMI)
between groups was not substantial, mean BMI 27.1 in
the laparoscopic group versus BMI 26.7 in the open
group. The heaviest woman (BMI 43.1) successfully
underwent laparoscopically assisted vaginal hysterecto-
my, and pelvic and para-aortic lymph node dissection.
More than half of the patients in the laparoscopic group
(52.1%) weighed more than 81.7kg/180 pounds. 
Adenocarcinoma was the most common histology found
in both groups (Table 3). The frequency of poorly dif-
ferentiated lesions (Grade 2, 3), (laparoscopy group
75.0% vs open group 79.1%) and lesions invading up to
50% of the myometrium was similar in both groups. Of
the 92 patients who underwent laparoscopic lym-
phadenectomy, 25 patients also had para-aortic lymph
node dissection or sampling with 4 positive results for
metastases. We found malignant changes in lymph nodes
in 11 women (11.9%) in the laparoscopic group versus 3
women (12.5%) in the control group. The average num-
bers of removed lymph nodes in our groups were com-
parable (19 LPSC group vs 17 open group). 
Table 2.
Outcomes and Length of Hospital Stay.
Outcome Laparoscopy Control Group t test
Duration of surgery
(min) 173.8 135.0 P < 0.0001
(range) (120-220) (95-180)
Number of nodes 
recovered 19.0 17.0 NS
(range) (3-34) (6-26)
Estimated blood loss (mL) 201.2 225.7 NS
Hospital stay (days) 4.1 7.7 P < 0.0001
(range) (2-16) (5-16)
Table 3.
Results of Histological Examination.
Histological Finding  Laparoscopy Control Group
Adenocarcinoma 83 20
Adenoacanthomas 2 1
Papillary carcinoma 2 1
Adenosquamous carcinoma 3 1
Clear-cell carcinoma 1 1
Carcinosarcoma 1 0
Table 4.
Surgical Staging.
Stage Laparoscopy Control Group 
Stage Ia (no myoinvasion) 20 4
Stage Ib (to 50%) 38 8
Stage Ic (over 50%) 19 7
Stage IIa 0 1
Stage IIb 1 1
Stage IIIa 3 0
Stage IIIc 11 3
Lymph node positive (cases) 11 3
Pelvic lymph node 7 3
Para-aortic lymph node 1 0
Both lymph nodes positive 3 1
Grade 1 23 5
Grade 2 36 10
Grade 3 33 9The blood loss was minimal and only 3 units were
required for transfusion in the 3 patients with conversion
for uncontrolled intraoperative bleeding. Preoperative
blood loss was comparable in both groups (201.2 mL vs
225.7 mL in the laparoscopic and open group, respec-
tively) without any significant consecutive changes in the
serum hemoglobin value. 
Although the length of operating time for a laparoscopic
hysterectomy and lymphadenectomy was significantly
longer than the time for the laparotomy procedure (173.8
min vs. 135.0 min, P < 0.0001), the laparoscopic group
patients were discharged from hospital much earlier, at
4.1 days (range 2 to 16) after the laparoscopic procedure,
compared with 7.7 days (range 5 to 16) after the abdom-
inal procedure (P < 0.0001). 
The patients who underwent operation at 1 particular
center had the longest average duration of hospital stay
(8.6 days). This center also had the longest operating
time (220 min), the highest number of excised lymph
nodes (26), and the most severe complications. All the
patients, regardless of the surgical approach chosen,
were treated postoperatively on the same clinical treat-
ment pathways. The median follow-up in the laparo-
scopic group was 21 months (range 3 to 48). One case
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of adenocarcinoma of the sigmoideum was found (sec-
ond malignancy or recurrence) during surgical stage I.
The median follow-up in the control group was 23
months (range 2 to 46), without any recurrence during
surgical stage I and with 1 death during clinical stage I. 
DISCUSSION 
Endometrial cancer is now a surgically staged malignan-
cy. The pilot study by Creasman et al8 and subsequent
reports of the GOG studies have been instrumental in
this change. These reports document the significance of
lymph node involvement. This study has recorded the
spread to pelvic and para-aortic lymph nodes in 6% to
9% of cases where only the corpus is involved, and over-
all, a 22% incidence of extrauterine spread. Benedetti-
Panici et al9 analyzed the patterns of lymphatic spread in
91 endometrial cancer patients [surgical Federation
International of Obstetrics and Gynecology (FIGO) stage
I-IV] who underwent systematic pelvic and aortic lym-
phadenectomy. If regional lymph node sampling is done,
some degree of additional morbidity is incurred. Several
authors have retrospectively evaluated the morbidity and
mortality of lymphadenectomy done by the open proce-
dure of staging laparotomy.10,11 Barakat and Benjamin12
noted a statistically significant increase in perioperative
parameters (mean operating time, blood loss, and dura-
tion of hospital stay). 
Childers et al1 reported on a series of 59 patients consid-
ered candidates for laparoscopically assisted surgical
staging (LASS) for management of their clinical stage I
adeno-carcinoma of the endometrium. These authors
carried out pelvic and para-aortic lymph-adenectomy on
23 patients and were unable to perform laparoscopic
common and para-aortic lymphadenectomy in 2 other
patients because of obesity. Several authors concluded
that removal of both pelvic and para-aortic lymph nodes
can be accomplished laparoscopically even in obese
patients.13-16 However, at present, no agreement exists
about indications and extent with regard to lym-
phadenectomy. Even in the presence of other pelvic
pathology, obesity does not seem to limit the pelvic lym-
phadenectomy, allowing these women with endometrial
and cervical cancer to be candidates for the proce-
dures.13 In addition, primary removal of aortic nodes is
not warranted in most women with endometrial cancer
and should be restricted to pelvic lymph nodes.13,14 In
our previous study, we assessed differences in duration
Table 5.
Complications.
Type of Complications Laparoscopy Control Group
Fever over 38°C 6 2
Hematoma 2 0
Wound abscess 1 2
Vaginal discharge 2 0
Phlebothrombosis 1 1
Pulmonary artery embolism 1 0
Injury to a. epigastrica 3 0
Injury to bladder 2 1
Neuritis n. obturatorii 1 0
Conversion 4* 0
Totals 23 6
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of surgery, number of excised lymph nodes, blood loss,
and hospital stay after LASS in 2 groups of women of dif-
ferent weight with endometrial cancer.16 It was surprising
that the duration of surgery was shorter by 6 minutes in
obese than in nonobese patients; the mean operating
time was 166 and 172 minutes, respectively. 
The results of our study shows that laparoscopy and the
open procedure were similar in terms of perioperative
outcomes in blood loss and the number of nodes recov-
ered. The great effectiveness and reliability of the elec-
trosurgical and ultrasonic operational techniques used
were confirmed. Furthermore, electrosurgery was
demonstrated to be superior to the Harmonic scalpel in
cases of venous bleeding on v. ovarica during the salpin-
go-oophorectomy phase. The advantages of the
LaparoSonic technique include less charring and plume,
better visualization, and less thermal injury, particularly in
respect to the important surrounding pelvic structures
during lymph node dissection.17 The rate of major and
moderate complications was higher in the control group
(25.0% vs. 23.0%). In 4 cases, the laparoscopic procedure
was converted to laparotomy. In 1 patient of the 3 cases
of uncontrolled bleeding from an injured branch of the
iliac vein, laparoscopy was followed by laparotomy and
multiple complications were induced (wound abscess,
resuture, and pulmonary artery microembolism). In 1
patient in the laparoscopy group, the nervus obturatorius
was irritated during the pelvic lymph node dissection
done by the ultrasonic scissors. We suppose that the
higher complication rate at 1 particular center is related
to the greater radicalism of the surgery and the higher
para-aortic lymphadenectomy rate. 
Outcomes of the surgical treatment and follow-up were
similar in both groups. Although the length of the opera-
tive time for laparoscopic procedure was significantly
longer (P < 0.0001) than the time for the open procedure,
the laparoscopic group patients were discharged from the
hospital significantly earlier (P < 0.0001). 
Among the 69 patients in the laparoscopic group with
higher stage grading and deep myometrial invasion, only
PLN was carried out in 44, and both PLN and PALN were
also done in 25. In this group, the malignant changes in
lymph nodes were confirmed in 10 women (14.5%) and
in only 1 patient in the group of 23 women with low
grading and myoinvasion less than 50%. The total num-
ber of women with pathologic lymph node and positive
peritoneal cytology was 14 (15.2%). In these cases, clini-
cal evaluation alone may lead to understaging. Metastasis
was found in 12.5% of the patients in the control group.
In the above mentioned recent study of Benedetti-Panici
et al,9 nodal involvement was found in 16 cases (18%),
but lymph node metastasis was the only site of occult
extrauterine spread in 5 patients (6.6%). In a retrospec-
tive chart review of 320 patients with early-stage
endometrial cancer treated by laparoscopic assisted vagi-
nal hysterectomy (LAVH) or total abdominal hysterecto-
my (TAH) described by Gemignani et al,18 no significant
difference existed between either method in mean lymph
node yield. Grade 1 tumors were the majority of the
tumors in both groups, and the number of the patients
with lymph node positivity was not specified. 
We found only 1 case of positive aortic node without
involvement of pelvic nodes, which is in accordance
with reports of others.9,13 Pelvic node metastasis is a bet-
ter criterion for aortic lymphadenectomy than is myome-
trial invasion.19 According to findings of Bendetti-Panici
et al9 in the pelvic area, the superficial obturator nodes
were the frequently involved group. Evaluation of these
nodes alone identified 71% of patients with positive
nodes. On the other hand, when the external iliac and
superficial common iliac nodes were evaluated together
with the superficial obturator group, all patients having
pelvic metastases were identified. According to recom-
mendations of the FIGO Committee on Gynecologic
Oncology,20 indications for aortic node sampling would
include suspicious aortic or common iliac nodes, grossly
positive adnexa, and any grade of tumor showing the
outer half of myometrial invasion. Patients with clear cell
papillary serous or carcinosarcoma histologic subtypes
are also candidates for aortic node sampling. Although
mandated through the staging system, lymphadenectomy
of the pelvis and para-aortic areas remains controversial,
with most individuals using selective node sampling and
reserving complete lymphadenectomy for cases with cer-
tain high-risk features. In clinical practice guidelines from
FIGO, the open approach to surgery for endometrial can-
cer is generally recommended. It was recently stated20
that laparoscopically assisted vaginal hysterectomy and
laparoscopic lymphadenectomy are procedures that are
appropriate, when applicable. Kadar14 suggests using the
2-stage approach to aortic lymphadenectomy in obese or
high-risk patients. In our opinion, laparoscopic pelvic
lymphadenectomy has a significant role in surgical stag-
ing in patients with endometrial cancer. Prolongation of
the operation time from 60 to 80 minutes on average
increasing the risk of serious adverse events is acceptable
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tion are compared. The follow-up result is another rea-
son for inclusion of the pelvic lymphadenectomy as a
firm part of surgical staging of patients with high-risk
endometrial carcinoma. No deaths or port site metastases
were observed during the follow-up period in the group
of patients with surgical stage I endometrial carcinoma.
Adenocarcinoma of the sigmoideum was found in 1
patient with negative pelvic nodes 3 months after hys-
terectomy with lymphadenectomy (recurrence rate
98.5%). 
CONCLUSION
The laparoscopic approach to pelvic lymphadenectomy
for early stage endometrial cancer is an attractive alter-
native to the open surgical approach. The advantages of
laparoscopically assisted surgical staging are patient
related. The laparoscope affords a surgeon the ability to
avoid abdominal incision wound infection in these
patients. The women who underwent the laparoscopic
procedure had a short postoperative stay in the hospital.
This approach also allows women to have all the bene-
fits of minimally invasive surgery, such as less pain, less
scarring, and a shorter recovery time. 
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